an Istitution Experience on Parosteal OsTeosarcoma

Parosteal OsTeosarcoma: a Single Istitution Experience

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03768076

Enrollment

220

Registered

2018-12-07

Start date

2018-11-30

Completion date

2019-02-28

Last updated

2021-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parosteal Osteosarcoma

Brief summary

single institution cases series review of histological and clinical data

Detailed description

Investigators will review all the cases with a diagnosis of primary parosteal osteosarcoma treated at the Rizzoli Institute from 1900 up to 31 July 2018, retrospectively.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Male and female patients treated at Rizzoli Institute from 01 Jan 1900 to 31 Jul 2018 * Diagnosis of parosteal osteosarcoma * Written informed consent prior to any study-specific analysis and/or data collection

Exclusion criteria

• Patients with histological diagnosis different from parosteal osteosarcoma

Design outcomes

Primary

Measure	Time frame	Description
retrospective analysis of cases of Parosteal osteosarcoma	at baseline (Day0)	Investigators will exam the presence of progression (dedifferentiation) areas and the relationship of these factors to individual outcome.

Countries

Italy

Outcome results